NCT03749187 2026-03-13PNOC017University of California, San FranciscoPhase 1 Active not recruiting78 enrolled
NCT05652283 2024-11-27Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian CancerAnhui Provincial Cancer HospitalPhase 2 Active not recruiting37 enrolled